- Home
- SMTI vs NMRA Comparison
SMTI vs NMRA Comparison
Compare SMTI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- NMRA
- Stock Information
- Founded
- SMTI 1982
- NMRA 2019
- Country
- SMTI United States
- NMRA United States
- Employees
- SMTI N/A
- NMRA N/A
- Industry
- SMTI Medical/Dental Instruments
- NMRA
- Sector
- SMTI Health Care
- NMRA
- Exchange
- SMTI Nasdaq
- NMRA Nasdaq
- Market Cap
- SMTI 288.2M
- NMRA 287.6M
- IPO Year
- SMTI N/A
- NMRA 2023
- Fundamental
- Price
- SMTI $33.64
- NMRA $1.16
- Analyst Decision
- SMTI Strong Buy
- NMRA Buy
- Analyst Count
- SMTI 2
- NMRA 8
- Target Price
- SMTI $47.00
- NMRA $10.14
- AVG Volume (30 Days)
- SMTI 22.1K
- NMRA 1.4M
- Earning Date
- SMTI 05-12-2025
- NMRA 03-03-2025
- Dividend Yield
- SMTI N/A
- NMRA N/A
- EPS Growth
- SMTI N/A
- NMRA N/A
- EPS
- SMTI N/A
- NMRA N/A
- Revenue
- SMTI $78,056,873.00
- NMRA N/A
- Revenue This Year
- SMTI $35.26
- NMRA N/A
- Revenue Next Year
- SMTI $20.79
- NMRA N/A
- P/E Ratio
- SMTI N/A
- NMRA N/A
- Revenue Growth
- SMTI 24.66
- NMRA N/A
- 52 Week Low
- SMTI $26.00
- NMRA $1.14
- 52 Week High
- SMTI $39.08
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- SMTI 50.89
- NMRA 24.42
- Support Level
- SMTI $30.81
- NMRA $1.26
- Resistance Level
- SMTI $32.90
- NMRA $1.48
- Average True Range (ATR)
- SMTI 1.42
- NMRA 0.13
- MACD
- SMTI 0.05
- NMRA 0.06
- Stochastic Oscillator
- SMTI 61.55
- NMRA 5.77
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.